ERS International Congress 2022: highlights from the Basic and Translational Science Assembly.
Détails
Télécharger: 37077558_BIB_8FD20E595943.pdf (813.01 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_8FD20E595943
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
ERS International Congress 2022: highlights from the Basic and Translational Science Assembly.
Périodique
ERJ open research
ISSN
2312-0541 (Print)
ISSN-L
2312-0541
Statut éditorial
Publié
Date de publication
2023
Peer-reviewed
Oui
Volume
9
Numéro
2
Pages
00561-2022
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
In this review, the Basic and Translational Science Assembly of the European Respiratory Society provides an overview of the 2022 International Congress highlights. We discuss the consequences of respiratory events from birth until old age regarding climate change related alterations in air quality due to pollution caused by increased ozone, pollen, wildfires and fuel combustion as well as the increasing presence of microplastic and microfibres. Early life events such as the effect of hyperoxia in the context of bronchopulmonary dysplasia and crucial effects of the intrauterine environment in the context of pre-eclampsia were discussed. The Human Lung Cell Atlas (HLCA) was put forward as a new point of reference for healthy human lungs. The combination of single-cell RNA sequencing and spatial data in the HLCA has enabled the discovery of new cell types/states and niches, and served as a platform that facilitates further investigation of mechanistic perturbations. The role of cell death modalities in regulating the onset and progression of chronic lung diseases and its potential as a therapeutic target was also discussed. Translational studies identified novel therapeutic targets and immunoregulatory mechanisms in asthma. Lastly, it was highlighted that the choice of regenerative therapy depends on disease severity, ranging from transplantation to cell therapies and regenerative pharmacology.
Pubmed
Web of science
Open Access
Oui
Création de la notice
01/05/2023 10:04
Dernière modification de la notice
25/01/2024 7:40